Neuronal Aquaporin 1 Inhibits Amyloidogenesis by Suppressing the Interaction Between Beta-Secretase and Amyloid Precursor Protein.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 18 10 2019
pubmed: 11 3 2020
medline: 16 7 2021
entrez: 11 3 2020
Statut: ppublish

Résumé

The accumulation of amyloid-β (Aβ) is a characteristic event in the pathogenesis of Alzheimer's disease (AD). Aquaporin 1 (AQP1) is a membrane water channel protein belonging to the AQP family. AQP1 levels are elevated in the cerebral cortex during the early stages of AD, but the role of AQP1 in AD pathogenesis is unclear. We first determined the expression and distribution of AQP1 in brain tissue samples of AD patients and two AD mouse models (3xTg-AD and 5xFAD). AQP1 accumulation was observed in vulnerable neurons in the cerebral cortex of AD patients, and in neurons affected by the Aβ or tau pathology in the 3xTg-AD and 5xFAD mice. AQP1 levels increased in neurons as aging progressed in the AD mouse models. Stress stimuli increased AQP1 in primary cortical neurons. In response to cellular stress, AQP1 appeared to translocate to endocytic compartments of β- and γ-secretase activities. Ectopic expression of AQP1 in human neuroblastoma cells overexpressing amyloid precussir protein (APP) with the Swedish mutations reduced β-secretase (BACE1)-mediated cleavage of APP and reduced Aβ production without altering the nonamyloidogenic pathway. Conversely, knockdown of AQP1 enhanced BACE1 activity and Aβ production. Immunoprecipitation experiments showed that AQP1 decreased the association of BACE1 with APP. Analysis of a human database showed that the amount of Aβ decreases as the expression of AQP1 increases. These results suggest that the upregulation of AQP1 is an adaptive response of neurons to stress that reduces Aβ production by inhibiting the binding between BACE1 and APP.

Identifiants

pubmed: 32154567
pii: 5802437
doi: 10.1093/gerona/glaa068
pmc: PMC7756701
doi:

Substances chimiques

Amyloid 0
Amyloid beta-Protein Precursor 0
Aquaporin 1 146410-94-8
Amyloid Precursor Protein Secretases EC 3.4.-

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-31

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Prog Brain Res. 2007;161:185-94
pubmed: 17618977
Nat Rev Neurosci. 2003 Dec;4(12):991-1001
pubmed: 14682361
J Biol Chem. 2008 Sep 12;283(37):25492-502
pubmed: 18599481
J Cell Sci. 2005 Aug 1;118(Pt 15):3225-32
pubmed: 16079275
Acta Neuropathol. 2003 Aug;106(2):121-4
pubmed: 12715185
Elife. 2016 Nov 11;5:
pubmed: 27834631
J Alzheimers Dis. 2011;24(2):349-61
pubmed: 21258150
Mol Neurodegener. 2015 Nov 02;10:58
pubmed: 26526066
Brain Res Mol Brain Res. 2000 May 31;78(1-2):131-7
pubmed: 10891592
FASEB J. 2005 Jan;19(1):76-8
pubmed: 15533949
Ann Neurol. 2015 Mar;77(3):504-16
pubmed: 25558977
Am J Physiol Cell Physiol. 2006 Jul;291(1):C59-67
pubmed: 16481371
Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12516-12523
pubmed: 31164420
Science. 2004 Sep 10;305(5690):1573-4
pubmed: 15361612
Nat Rev Drug Discov. 2010 Oct;9(10):749-51
pubmed: 20885394
Nat Rev Neurosci. 2013 Apr;14(4):265-77
pubmed: 23481483
Brain Res. 2007 Jan 12;1128(1):164-74
pubmed: 17123487
Alzheimers Res Ther. 2013 Oct 08;5(5):46
pubmed: 24103387
Biochem Biophys Res Commun. 2000 Oct 5;276(3):1118-28
pubmed: 11027599
Glia. 2019 Jan;67(1):91-100
pubmed: 30306658
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9
pubmed: 3159021
Acta Neuropathol. 2006 Nov;112(5):573-85
pubmed: 16871401
Neuropathology. 2007 Jun;27(3):245-56
pubmed: 17645239
Acta Neurochir Suppl. 2006;96:398-401
pubmed: 16671493
Biochem Biophys Res Commun. 2011 Jan 7;404(1):10-5
pubmed: 21130746
Nat Med. 2000 Feb;6(2):159-63
pubmed: 10655103
Am J Pathol. 2000 Jan;156(1):15-20
pubmed: 10623648
Neurosci Lett. 2010 Jan 29;469(3):391-5
pubmed: 20026385
Aging Cell. 2012 Aug;11(4):559-68
pubmed: 22404891
Pediatr Neurosurg. 2017;52(6):409-416
pubmed: 27978530
Ann N Y Acad Sci. 1994 Dec 15;747:50-76
pubmed: 7847692
J Neurosci. 2017 May 17;37(20):5099-5110
pubmed: 28432138
Nat Med. 2003 Apr;9(4):453-7
pubmed: 12612547
Acta Neurochir Suppl. 2006;96:389-92
pubmed: 16671491
Science. 1990 Apr 27;248(4954):492-5
pubmed: 1691865
Br J Cancer. 2002 Sep 9;87(6):621-3
pubmed: 12237771
J Neurochem. 2012 Jan;120 Suppl 1:125-39
pubmed: 22121920
Cerebrospinal Fluid Res. 2010 Sep 22;7:15
pubmed: 20860832
Metab Brain Dis. 2007 Dec;22(3-4):251-63
pubmed: 17701333
FASEB J. 2009 Dec;23(12):4158-67
pubmed: 19687153
Acta Neuropathol. 2008 Sep;116(3):247-60
pubmed: 18509662
J Biol Chem. 2005 Sep 30;280(39):33220-7
pubmed: 16014628
J Neurosci. 1997 Jan 1;17(1):171-80
pubmed: 8987746
Neuron. 2003 Jul 31;39(3):409-21
pubmed: 12895417
Mol Neurodegener. 2013 Jan 14;8:2
pubmed: 23316765
Biochem Biophys Res Commun. 2000 Apr 13;270(2):495-503
pubmed: 10753653
Mol Neurodegener. 2009 Nov 23;4:48
pubmed: 19930651

Auteurs

Jinsu Park (J)

School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Department of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.

Meenu Madan (M)

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando.

Srinivasulu Chigurupati (S)

Bio-Imaging, Division of Neurotoxicology, National Center for Toxicological Research, Jefferson, Arkansas.
Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Seung Hyun Baek (SH)

School of Pharmacy, Sungkyunkwan University, Suwon, Korea.

Yoonsuk Cho (Y)

School of Pharmacy, Sungkyunkwan University, Suwon, Korea.

Mohamed R Mughal (MR)

Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Amin Yu (A)

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando.

Sic L Chan (SL)

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando.

Jogi V Pattisapu (JV)

Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando.

Mark P Mattson (MP)

Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Dong-Gyu Jo (DG)

School of Pharmacy, Sungkyunkwan University, Suwon, Korea.
Department of Health Science and Technology, Sungkyunkwan University, Seoul, Korea.
Biomedical Institute for Convergence, Sungkyunkwan University, Suwon, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH